SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16242Robert, you mentioned your occupation several years ago. You replied to someonaknahow-9/1/2003
16241I am not talking about your posts here.Robert K.-9/1/2003
16240George, I would appreciate it if you would be more respective of whatever personRobert K.-9/1/2003
16239Bermuda, is not your issue. You have clearly defined your issue as a political aknahow-8/31/2003
16238Ed, I hope you are kidding. I owe more shares to a family member than I own, buaknahow-8/29/2003
16237As of this morning I have taken a short position in Xoma. It is ludicrous that Edscharp-8/14/2003
16236Lets not forget that once approval is obtained, then simplification becomes possRobert K.-8/9/2003
16235Bluegreen> I found your methotrexate quite interesting so I posted your idea Robert K.-8/9/2003
16234Press Release Source: Genentech, Inc. New Data Support Raptiva as a Potential tom r. phillips-7/26/2003
16233Time pass by and I agree with you more. Look, the Fda gave Baxter the right to aCacaito-7/13/2003
16232Which is worse Cacaito......allowing a Meningo. trial that allows several hours Bluegreen-7/12/2003
16231The $10 million payment doesn't reflect negatively on Raptiva. It was probaLarryS-7/10/2003
16230What is it they say about alimony..."It's the high cost of leaving"Arthur Radley-7/9/2003
16229Tex, Interesting article. You have to wonder about the perceived efficacy of nEdscharp-7/9/2003
16228Cacaito, why wouldn't Methotrexate wipe out the effects of Raptiva??? I assBluegreen-7/9/2003
16227Excellent, Baxter was long proven inept (including other products with other smaCacaito-7/8/2003
16226XOMA strikes pay dirt once again...NOT!!! biz.yahoo.comArthur Radley-7/8/2003
16225Gw, the numbers are from UBS (Expainewebber)Merah Chovav (or something like thatCacaito-7/7/2003
16224How can you say "still quite good"? Would you please provide a sourceaknahow-7/7/2003
16223Amevive sales now projected lower to: $40M in 2003 $80M in 2004 $175 in 2005 $Cacaito-7/5/2003
16222Why the drop !!! Dna got Xolair approval (as many problems as Raptiva applicatiCacaito-7/5/2003
16221Gw, too busy posting at his favorite xoma and... xomagroup and biogen.Cacaito-6/2/2003
16220An APB for George Wohanka...it has been since last October that George posted heArthur Radley-5/29/2003
16219So much for Raptiva. Xoma might be the unluckiest biotech in existence. What is Edscharp-5/13/2003
16218The real question is this. Come october 2003 can you see xoma at $4 level? $3 lRobert K.-4/1/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News